Viviant (bazedoxifene)

By Business Review Editor

Pharma Deals Review: Vol 2007 Issue 86 (Table of Contents)

Published: 7 Aug-2007

DOI: 10.3833/pdr.v2007.i86.300     ISSN: 1756-7874

Section: Deal Trackers



Bazedoxifene is a third-generation selective oestrogen receptor modulator (SERM), which originated with Ligand Pharmaceuticals as TSE-424, a treatment for postmenopausal osteoporosis (PMO), and has been developed in an alliance which began in September 1994 with Wyeth-Ayerst Laboratories, of American Home Products (AHP)...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details